How Does Patent Evergreening Affect Drug Accessibility?
When pharmaceutical companies engage in patent evergreening, they effectively delay the introduction of cheaper, generic versions of cancer drugs. This can result in prolonged periods where patients have limited access to affordable treatments. For many cancer patients, this can mean the difference between receiving timely care or facing financial hardship.
